ERBB2 and breast cancer: Immunohistochemical analysis indicated positivity for estrogen receptor, progesterone receptor, HER2/neu, and a Ki67 proliferation index of 60%, categorizing this breast cancer molecularly as luminal B HER2-positive subtype.